Kole H K, Akamatsu M, Ye B, Yan X, Barford D, Roller P P, Burke T R
Laboratory of Medicinal Chemistry, DCT, NCI, National Institutes of Health, Bethesda, MD 20892, USA.
Biochem Biophys Res Commun. 1995 Apr 26;209(3):817-22. doi: 10.1006/bbrc.1995.1573.
Peptides containing phosphonate based non-hydrolyzable phosphotyrosyl (pTyr) mimetics previously have been shown to be competitive inhibitors of protein-tyrosine phosphatases (PTPs). These agents suffer from low cellular penetration which is partially attributable to ionization of the phosphonate group at physiological pH. We have developed the non-phosphorus containing pTyr mimetic, L-O-malonyltyrosine (L-OMT) and herein demonstrate using a PTP 1B enzyme assay that it is superior to phosphonomethyl phenylalanine (Pmp) as a pTyr mimetic when incorporated into the hexamer peptide Ac-D-A-D-E-X-L-amide (X = D,L-Pmp, IC50 = 200 microM; X = L-OMT, IC50 = 10 microM). Prodrug protection of L-OMT as its carboxylic acid diester could potentially increase cellular penetration, thereby making this a valuable reagent for cellular studies.
先前已表明,含有基于膦酸酯的不可水解磷酸酪氨酸(pTyr)模拟物的肽是蛋白酪氨酸磷酸酶(PTP)的竞争性抑制剂。这些试剂存在细胞穿透性低的问题,这部分归因于膦酸酯基团在生理pH下的离子化。我们开发了不含磷的pTyr模拟物L-O-丙二酰酪氨酸(L-OMT),并在此使用PTP 1B酶测定法证明,当将其掺入六聚体肽Ac-D-A-D-E-X-L-酰胺(X = D,L-Pmp,IC50 = 200 microM;X = L-OMT,IC50 = 10 microM)中时,作为pTyr模拟物,它优于膦酰甲基苯丙氨酸(Pmp)。L-OMT作为其羧酸二酯的前药保护可能会增加细胞穿透性,从而使其成为细胞研究的有价值试剂。